DANIEL LYNCH
CIK 1177082 · Chairman · last filed 2025-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
9
Total Filings
74
Lifetime Open-Market Net
-$26.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 0 | $46.99 | $0 | -$12.42M | 11 | 2025-07-02 |
| 2seventy bio, Inc. (TSVT) Delisted | Director | 21,053 | $5.00 | $105.3K | $0 | 3 | 2023-06-15 |
| bluebird bio, Inc. (BLUE) Delisted | Director | 7,959 | $4.97 | $39.6K | -$8.17M | 27 | 2021-11-17 |
| Blueprint Medicines Corp (BPMC) Delisted | Director | 127,904 | $129.46 | $16.56M | -$5.84M | 18 | 2020-06-26 |
| TBIO | Director | — | $0.00 | — | $0 | 2 | 2020-06-17 |
| Surface Oncology, Inc. (SURF) Delisted | Director | — | $1.07 | — | $0 | 2 | 2020-06-12 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | — | $12.58 | — | $0 | 2 | 2019-06-21 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Director | 161,430 | — | — | $0 | 4 | 2017-05-23 |
| DNIB UNWIND, INC. (BIND) Delisted | Director | — | — | — | $0 | 4 | 2016-06-22 |
Recent Filings · Page 5 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-06-12 | bluebird bio, Inc. (BLUE) Delisted | Mixed | +1,400 | -$270.3K | EDGAR |
| 2017-06-08 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$221.9K | EDGAR |
| 2017-06-07 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$87.9K | EDGAR |
| 2017-05-30 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$155.8K | EDGAR |
| 2017-05-23 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-01 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$87.9K | EDGAR |
| 2017-04-27 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$169.3K | EDGAR |
| 2017-03-28 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$258.1K | EDGAR |
| 2017-03-20 | bluebird bio, Inc. (BLUE) Delisted | Mixed | — | -$23.2K | EDGAR |
| 2017-03-16 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −7,500 | -$300.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.